The treatment of Choice for Actinic keratoses, Basal cell carcinoma, Squamous cell carcinoma.
Curaderm-BEC5 Topical cream
Curaderm-BEC5 has recorded over 100,000 successful and safe removals. The main advantages of Curaderm-BEC5 being:
1. The BEC5 active, patented since the early 1980’s is Cancer specific technology that identifies and eliminates only the cancerous growths within the skin dermis. Research Phase 3 and 4 clinical trials released in 2002 by Royal London Hospital (UK) and ten Skin cancer clinics confirmed the specific cancer removing technology advantages over all other treatments.
2. Healthy skin tissue around the cancer cells are maintained and the BEC5 protects the healthy skin cells so that once cancer is gone, the healthy cells multiply so normal beautiful skin tissue is quickly and easily restored.
3. Because the BEC5 keeps tracking and tracking then destroying all the cancer cells one by one, to the millions! Cancer cells always, by definition, clump together and line up in rows, multiplying and taking over the space of healthy cells. Because BEC5 traces them all the way, the eye does not need to see and scrape out the cancer cells as with surgery. The fact that every cancer cell is removed in the Curaderm-BEC5 process means there is no chance of recurrence! This is an unquestionable advantage as every other treatment except Curaderm-BEC5 does incur returned skin cancers after failed treatments up to 30% of the time.
4. Curaderm-BEC5 Treatments do not require any post treatment medical operation such as reconstructive surgery, plastic surgery, skin grafting, injections or any other such medical operations.
Curaderm’s mechanism of action is different and allows it to kill cancer cells, and only cancer cells.
Other anti-cancer drugs kill cells by interfering with mitosis, the process through which cells divide and replicate. Cancer cells undergo mitosis much more frequently than normal cells, so killing all dividing cells causes the death of many more cancerous than normal cells, but these drugs kill not only cancer cells, but also normal cells while they are dividing.
Curaderm’s mechanism of action is different and allows it to kill cancer cells, and only cancer cells, regardless of whether they are dividing or “resting”. Cancer cells have large numbers of a specific receptor on their surface that recognizes and binds BEC, which is then drawn inside the cancer cell and taken up by its “stomach” (lysosomes). When the lysosomes digest BEC, solasodine is generated and causes the lysosome to rupture, spilling its contents—digestive enzymes—into the cell. The cancer cell’s own digestive enzymes then proceed to digest the cell, causing its death through apoptosis (more like an organized disassembly process than a death). The fact that BEC kills cancer cells by triggering the natural process of apoptosis is key to its elegance: BEC preserves the natural healing processes for rebuilding the normal tissue that was lost to the cancer.
Normal cells either completely lack this receptor or have only an extremely small amount of it, so BEC cannot attach to normal cells.